Arne Östman

Arne Östman

Professor
Visiting address: J6:20 BioClinicum, Akademiska stråket 1, 17164 Solna
Postal address: K7 Onkologi-Patologi, K7 Forskning Östman, 171 77 Stockholm

About me

  • Professor, Dept of Oncology-Pathology, Karolinska Institutet, 2006- Professor II, CCBIO, Bergen University, 2016- Education Associate Professor, Uppsala University, 1995 Post-doc, Cold Spring Harbor Laboratory, 1992-93 Ph.D., Uppsala University, Selected qualifications: Author of more than 170 original research articles and 45+ reviews (Nat Rev Can (2), Cancer Cell, Trends in Cell Biology and Trends in Cancer)
  • h-factor 68 (Web of Science). Completed supervision of 14 PhD students and 22 post-doctoral fellows of which the majority continues academic research. Six of these are full professors and 9 have been promoted to PI or junior PI positions. Coordinator STARGET – a Linnaeus center for translational studies on the tumor microenvironment with funding from VR 2006-16. Co-director StratCan – the strategic research program in cancer at Karolinska Institutet, 2010-18. Member of the Nobel assembly (2020-) and the Nobel committee (2023). Ad-hoc reviewer for the Nobel Assembly and the Royal Academy of Science (Sjöberg Prize). ERC Advanced Grant LS7 panel member (2023). Member of the Editorial Board Cancer Research (2015-). Member of the board of “Svenska Sällskapet för Medicinsk Forskning” (2020-). Supported by research grants from Swedish Cancer Society, Swedish Research Council, “Kreftforeningen”, Stockholm City Council (ALF), “Radiumhemmets forskningsfonder” and "HelseVest". External grant reviewer for Cancerfonden, Barncancerfonden, SSMF, ERC and national European agencies including CRUK and Wellcome Trust. Reviewer for e.g. Nature, Nature Medicine, Nat Comm., Nat Rev Cancer, Nat Rev Clin Onc, Cancer Cell, EMBO J. Main- or co-organizer of UICC Advanced Course of Cell Signaling and Cancer, 1999
  • Nobel Conference on Breast Cancer, 2012 and Swedish Cancer Research Meeting 2014. Ad hoc member of international scientific advisory boards for e.g. ImClone, Eli-Lilly and Novartis. Co-founder of TECKNET AB

Research

  • The Östman research group performs translation studies on autocrine and paracrine growth factor signaling in the tumor microenvironment, with particular emphasis on regulation of cancer-associated fibroblasts.

Selected publications

Articles

All other publications

Employments

  • Professor, Department of Oncology-Pathology, Karolinska Institutet, 2006-

Supervisor

  • Huang Linglong, 2021

News from KI

Events from KI